Compass Therapeutics | Investor Presentation Deck | 36 slides · page 12 of 36
Clinical trial schema showing randomization of 685 patients into Durvalumab+GemCis or Placebo+GemCis arms.
Pitch deck · appendix_methodology · plan_implementation · dense density
Slide locked Sign in to view
Slide schematic 7/7
diagram 1/1 list 3/3 paragraph 1/1 source-note 1/1 title 1/1
Components 7
process bullet bullet bullet paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1